Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.79 USD | +5.40% | +12.12% | -10.85% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.